Multiple reports state that Hims & Hers (HIMS) will partner with Novo Nordisk (NVO) to sell its GLP-1s through the telehealth company's platform. Marley Kayden covers the twists and turns of this tale, including fights over compounded dupes and a previous, failed attempt at a partnership. This also would help HIMS avoid legal action from GLP-1 makers. Prosper Trading Academy's Charles Moon offers an example options trade on HIMS.